These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25632196)

  • 41. Survival outcomes and patterns of failure after D2 dissection and adjuvant chemoradiotherapy for locally advanced gastric cancer: a retrospective study.
    Yang W; Hu R; Li GC; Zhou ML; Wang Y; Shen LJ; Liang LP; Zhang Z
    Br J Radiol; 2018 Sep; 91(1089):20170594. PubMed ID: 29927628
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
    Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
    Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis.
    Girardi DM; de Lima MA; Pereira GCB; Negrão MV; López RVM; Capareli FC; Sabbaga J; Hoff PMG
    BMC Cancer; 2018 Apr; 18(1):378. PubMed ID: 29614980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The efficacy of oral tegafur-uracil as maintenance therapy following intravenous 5-fluorouracil chemotherapy in stage III colon cancer.
    Hong KD; Lee SI; Moon HY
    Hepatogastroenterology; 2012; 59(113):104-7. PubMed ID: 22251527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patients with pathological stage N2 rectal cancer treated with early adjuvant chemotherapy have a lower treatment failure rate.
    Feng YR; Jin J; Ren H; Wang X; Wang SL; Wang WH; Song YW; Liu YP; Tang Y; Li N; Liu XF; Fang H; Yu ZH; Li YX
    BMC Cancer; 2017 Mar; 17(1):182. PubMed ID: 28279170
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
    Bahadoer RR; Dijkstra EA; van Etten B; Marijnen CAM; Putter H; Kranenbarg EM; Roodvoets AGH; Nagtegaal ID; Beets-Tan RGH; Blomqvist LK; Fokstuen T; Ten Tije AJ; Capdevila J; Hendriks MP; Edhemovic I; Cervantes A; Nilsson PJ; Glimelius B; van de Velde CJH; Hospers GAP;
    Lancet Oncol; 2021 Jan; 22(1):29-42. PubMed ID: 33301740
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A retrospective comparison of concurrent 5-fluorouracil or oral UFT in postoperative chemoradiation for gastric adenocarcinoma.
    Yoney A; Bati Y; Akboru H; Isikli L; Unsal M
    Cancer Radiother; 2010 Jan; 14(1):19-23. PubMed ID: 19963423
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.
    Kim S; Lim DH; Lee J; Kang WK; MacDonald JS; Park CH; Park SH; Lee SH; Kim K; Park JO; Kim WS; Jung CW; Park YS; Im YH; Sohn TS; Noh JH; Heo JS; Kim YI; Park CK; Park K
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1279-85. PubMed ID: 16099596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early initiation of fluorouracil-based adjuvant chemotherapy improves survival in patients with resectable gastric cancer.
    Qu JL; Qu XJ; Li X; Zhang JD; Teng YE; Jin B; Zhao MF; Yu P; Liu J; Li DY; Liu YP
    J BUON; 2015; 20(3):800-7. PubMed ID: 26214633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postoperative chemotherapy followed by conformal concomitant chemoradiotherapy in high-risk gastric cancer.
    Quero L; Bouchbika Z; Kouto H; Baruch-Hennequin V; Gornet JM; Munoz N; Cojean-Zelek I; Houdart R; Panis Y; Valleur P; Aparicio T; Maylin C; Hennequin C
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):574-80. PubMed ID: 22099038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adjuvant chemoradiation in gastric cancer: long-term outcomes and prognostic factors from a single institution.
    Bruixola G; Segura Á; Díaz-Beveridge R; Caballero J; Bennis MH; Palomar L; Giménez A; Mingol F; García-Mora C; Aparicio J
    Tumori; 2015; 101(5):517-23. PubMed ID: 26045120
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concomitant chemoirradiation for stage III-IV nasopharyngeal carcinoma in Chinese patients: results of a matched cohort analysis.
    Chua DT; Sham JS; Au GK; Choy D
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):334-43. PubMed ID: 12023137
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity.
    Lee AWM; Tung SY; Ng WT; Lee V; Ngan RKC; Choi HCW; Chan LLK; Siu LL; Ng AWY; Leung TW; Yiu HHY; O'Sullivan B; Chappell R
    Cancer; 2017 Nov; 123(21):4147-4157. PubMed ID: 28662313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Efficacy of Adjuvant FOLFOX6 for Patients With Gastric Cancer after D2 Lymphadenectomy: A Propensity Score-matched Analysis.
    Wang ZX; Yang XL; He MM; Wang F; Zhang DS; Li YH; Zhou ZW; Zhan YQ; Xu RH
    Medicine (Baltimore); 2016 Apr; 95(16):e3214. PubMed ID: 27100411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
    Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
    World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic significance of the concomitant existence of lymphovascular and perineural invasion in locally advanced gastric cancer patients who underwent curative gastrectomy and adjuvant chemotherapy.
    Hwang JE; Hong JY; Kim JE; Shim HJ; Bae WK; Hwang EC; Jeong O; Park YK; Lee KH; Lee JH; Cho SH; Chung IJ
    Jpn J Clin Oncol; 2015 Jun; 45(6):541-6. PubMed ID: 25759484
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is there a role for surgery with adequate nodal evaluation alone in gastric adenocarcinoma?
    Dudeja V; Habermann EB; Abraham A; Zhong W; Parsons HM; Tseng JF; Al-Refaie WB
    J Gastrointest Surg; 2012 Feb; 16(2):238-46; discussion 246-7. PubMed ID: 22089951
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adjuvant chemoradiotherapy versus adjuvant chemotherapy for R1 resected gastric cancer: a retrospective cohort study.
    Zhou ML; Li GC; Yang W; Deng WJ; Hu R; Wang Y; Long ZW; Liu XW; Wang YN; Zhang Z
    Br J Radiol; 2018 Sep; 91(1089):20180276. PubMed ID: 29906235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer.
    Cho JH; Lim JY; Cho JY
    World J Gastroenterol; 2017 Nov; 23(41):7407-7414. PubMed ID: 29151694
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
    J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.